ロード中...
A comparison of two doses of adriamycin in the primary chemotherapy of disseminated breast carcinoma.
Forty-eight patients with advanced breast carcinoma who had not received prior chemotherapy (minimum follow up 21 months) were randomised to receive either adriamycin 70 mg m-2 i.v. 3-weekly for 8 cycles (Regimen A) or adriamycin 35 mg m-2 i.v. 3-weekly for 16 courses (Regimen B). Objective response...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
1987
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2001830/ https://ncbi.nlm.nih.gov/pubmed/3318902 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|